A new treatment for Parkinson’s disease developed from decades of research at the University of Virginia has received ...
Montara Therapeutics is a biotechnology company developing therapies for brain diseases through its proprietary BrainOnly ...
A new meta-analysis of six randomized controlled trials finds that the 36 mg maintenance dose of the oral GLP-1 agonist ...
The company says its four-year lifespan screen found 60+ life-extending compounds, and a new advisory board will help chase them.
CHARLOTTESVILLE, VA ( CVILLE RIGHT NOW) – The U.S. Food and Drug Administration has approved a groundbreaking drug developed ...
Beactica Therapeutics AB, a Swedish precision medicine company, today announced the selection of BEA-28 as a preclinical candidate for its TEAD programme, which is aimed at developing novel therapies ...
Italfarmaco S.p.A., a global pharmaceutical company with established expertise in histone deacetylase (HDAC) biology and therapeutic development, and VeriSIM Life, an AI-enabled drug discovery and ...
YouTube on MSN
How statins quietly disrupt muscle cells
The biology behind muscle pain: calcium chaos, microscopic damage, and the overlooked mechanism that explains how statins can ...
Finding out which drug molecules will actually bind to which protein targets is one of the most fundamental questions in ...
Spread the loveIf you’re an adult living with obesity, you know the struggle is real. It’s not just about willpower or diet ...
A new study found that visits by people born outside of the U.S. to three LA emergency rooms dropped precipitously after ICE raids increased last year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results